HR 5381
International Pharmaceutical Transparency Act of 2019
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the International Pharmaceutical Transparency Act of 2019, aims to increase transparency in the pharmaceutical industry by requiring drug labels to clearly state the country of origin for each active ingredient. Currently, drug labels often don't include this information, making it difficult for consumers and healthcare providers to understand where the drug’s key components are sourced. The bill amends the Federal Food, Drug, and Cosmetic Act to mandate this labeling requirement. This change is intended to promote accountability and allow for better tracking of drug supply chains.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.